Skip to content

Exercise Training Effect in Patients With HF and PEF

Exercise Training Effect on Quality of Life and Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02696486
Enrollment
16
Registered
2016-03-02
Start date
2015-11-30
Completion date
Unknown
Last updated
2017-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

The purpose of this is to develop and implement a pilot study that will demonstrate the ability to recruit, enroll, retain, conduct exercise training, and collect pre and post outcomes on the effect of exercise training on quality of life (QOL) and exercise capacity in patients with a diagnosis of heart failure with preserved ejection fraction (HFPEF).

Interventions

BEHAVIORALExercise Training

Study subjects will receive medically supervised aerobic and resistance exercise training for 1 hour per session, 3 times per week for 6 weeks at the Cardiac Rehab center and then transition to home or YMCA partnership based exercise with staff follow-up contact for an additional 3 weeks.

Sponsors

Henry Ford Hospital
CollaboratorOTHER
MultiCare Health System Research Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 55 years (Interested in capturing mean ages close to age 65 as many HF initiatives are based on this age group and HF development increases with aging). * Diagnosis of HFPEF stable NYHA Stage II- III with an EF of ≥ 45% * Stabilized on cardiac medications and post hospitalization \> 4 weeks * Ability to participate in exercise testing and training. * Referral from Cardiologist or primary care physician.

Exclusion criteria

* Unstable Angina * Uncontrolled diabetes * Moderate to severe aortic stenosis * Uncontrolled hypertension Systolic BP\>150 mm Hg or Diastolic BP \>100 mm Hg * Valvular heart disease * Untreated coronary artery stenosis \>50% * Arrhythmias * Pulmonary disease/COPD * Dementia or cognitive impairment * VAD or Transplant planned in next 6 months. * Current or recent participation in a Cardiac Rehab program within the last six months.

Design outcomes

Primary

MeasureTime frame
Change in Quality of Life (QOL) score pre and post exercise training (ET).9 weeks

Secondary

MeasureTime frameDescription
Change in exercise capacity/tolerance pre and post ET using Cardiopulmonary Exercise Testing.9 weeksSymptom limited treadmill testing with expired gas measurement and analysis. Exercise capacity measured as Peak Vo2 (peak exercise oxygen uptake) in ml/min/kg. Continuous monitoring of 12 lead electrocardiogram and blood pressure measured every 2 minutes. Peak Vo2 defined as highest Vo2 value of the last 30 seconds before termination of exercise. Exercise time and peak workload will be measured for exercise tolerance.
Demonstrated ability to coordinate patient transition from clinic to home or YMCA partnership based exercise program with weekly staff follow-up within the study timeline.9 weeks
Capture 90 day hospital readmission data starting with study enrollment date and within the participants' study timeline.90 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026